| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/1999 | CA2134987C Substained release alginate fibre and process for the preparation thereof |
| 04/27/1999 | CA2129635C Method of ophthalmic drug delivery |
| 04/27/1999 | CA2122246C Phospholipid antimicrobial compositions |
| 04/27/1999 | CA2114678C Crystals of n-(trans-4-isopropylcyclohexylcarbonyl)- d-phenylalanine and methods for preparing them |
| 04/27/1999 | CA2111085C Extended-release form of diltiazem |
| 04/27/1999 | CA2097182C Method and device for treating tobacco addiction |
| 04/27/1999 | CA2096036C Method for stimulating intracellular synthesis of glutathione using esters of l-2-oxothiazolidine-4-carboxylate |
| 04/27/1999 | CA2087743C Pharmaceutical composition for inhibiting platelet aggregation |
| 04/27/1999 | CA2056823C Derivatives of 10,11,12,13-tetrahydrodesmycosin processes for preparation, and use thereof in pharmaceuticals |
| 04/27/1999 | CA2018085C Alpha-glycosyl hesperidin, and its preparation and uses |
| 04/27/1999 | CA1340519C Antiviral nucleosides |
| 04/27/1999 | CA1340513C Antitumor and antiviral alkaloids |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/23/1999 | CA2245997A1 Novel compounds |
| 04/23/1999 | CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
| 04/22/1999 | WO1999019505A1 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 04/22/1999 | WO1999019496A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | WO1999019487A1 Mammoglobin homolog |
| 04/22/1999 | WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 04/22/1999 | WO1999019481A2 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | WO1999019466A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/22/1999 | WO1999019365A1 Novel pectic polysaccharides purified from angelica gigas nakai and purification method and use as immuno-stimulating agent thereof |
| 04/22/1999 | WO1999019364A1 Dextran reduced in boron content, process for producing the same, and dextran packed in container in solution state |
| 04/22/1999 | WO1999019342A1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/22/1999 | WO1999019338A1 Inhibitors of nucleoside metabolism |
| 04/22/1999 | WO1999019332A1 Combined generation of phosphinic acid derivatives |
| 04/22/1999 | WO1999019325A1 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 04/22/1999 | WO1999019324A2 Antipsychotic substituted piperidine derivatives |
| 04/22/1999 | WO1999019323A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use |
| 04/22/1999 | WO1999019322A1 ETHYL 4-(8-CHLORO-5, 6-DIHYDRO-11H- BENZO[5,6]CYCLOHEPTA [1,2-b]PYRIDIN -11-YLIDENE)-1- PIPERIDENE CARBOXYLATE POLYMORPH |
| 04/22/1999 | WO1999019320A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | WO1999019319A1 Synthetic methods for polyphenols |
| 04/22/1999 | WO1999019317A1 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 04/22/1999 | WO1999019313A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| 04/22/1999 | WO1999019305A2 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 04/22/1999 | WO1999019304A2 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 04/22/1999 | WO1999019303A1 Pyrazole derivatives |
| 04/22/1999 | WO1999019302A1 Pyridyl compounds and pharmaceutical compositions containing them |
| 04/22/1999 | WO1999019301A1 Piperazine compounds and medicinal use thereof |
| 04/22/1999 | WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders |
| 04/22/1999 | WO1999019299A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
| 04/22/1999 | WO1999019298A1 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS |
| 04/22/1999 | WO1999019296A1 Aminobutanoic acid derivatives |
| 04/22/1999 | WO1999019295A1 Compositions and methods for inhibiting arginase activity |
| 04/22/1999 | WO1999019293A1 Novel aryloxy-alkyl-dialkylamines |
| 04/22/1999 | WO1999018985A1 Flavonolignan preparations, especially silymarin preparations |
| 04/22/1999 | WO1999018975A1 Leishmaniasis remedy containing glucopyranose derivative as the active ingredient |
| 04/22/1999 | WO1999018974A1 Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| 04/22/1999 | WO1999018973A2 Liquid presentations of oxazaphosphorine-containing pharmaceutical products |
| 04/22/1999 | WO1999018972A1 New improved formulation for treatment of osteoporosis |
| 04/22/1999 | WO1999018971A1 Mometasone furoate suspensions for nebulization |
| 04/22/1999 | WO1999018969A1 Remedial composition for intraocular hypertension or glaucoma |
| 04/22/1999 | WO1999018968A1 Portal hypertension inhibitor |
| 04/22/1999 | WO1999018967A1 Analgesic compositions |
| 04/22/1999 | WO1999018966A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 04/22/1999 | WO1999018965A1 Oral compositions containing a cephalosporin antibiotic |
| 04/22/1999 | WO1999018964A1 Zwitterionic compositions and methods as biological response modifiers |
| 04/22/1999 | WO1999018963A1 Use of flunarizine for the topical treatment of glaucoma |
| 04/22/1999 | WO1999018962A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | WO1999018961A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 04/22/1999 | WO1999018960A1 Novel combination |
| 04/22/1999 | WO1999018959A1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 04/22/1999 | WO1999018958A1 Bathocuproine treatment of neurologic disease |
| 04/22/1999 | WO1999018957A1 Stable pharmaceutical composition containing amlodipine besylate and atenolol |
| 04/22/1999 | WO1999018956A1 12(s)-hete receptor blockers |
| 04/22/1999 | WO1999018955A1 Percutaneously absorbable preparation |
| 04/22/1999 | WO1999018954A1 Antibacterial carbapenems, compositions and methods of treatment |
| 04/22/1999 | WO1999018953A1 Flavonoids for cystic fibrosis therapy |
| 04/22/1999 | WO1999018952A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 04/22/1999 | WO1999018951A1 Inhibitors of farnesyl protein transferase |
| 04/22/1999 | WO1999018950A1 Mixed cyanoacrylate ester compositions |
| 04/22/1999 | WO1999018949A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | WO1999018948A1 New use of npy antagonists |
| 04/22/1999 | WO1999018946A1 Methods for increasing schwann cell survival |
| 04/22/1999 | WO1999018945A1 Method of building and maintaining bone |
| 04/22/1999 | WO1999018944A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 04/22/1999 | WO1999018943A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 04/22/1999 | WO1999018942A1 Use of csaidtm compounds for the management of uterine contractions |
| 04/22/1999 | WO1999018941A2 Ih-MODULATORS |
| 04/22/1999 | WO1999018939A1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 04/22/1999 | WO1999018938A1 Delayed total release gastrointestinal drug delivery system |
| 04/22/1999 | WO1999018932A1 Novel once-a-day controlled release sulfonylurea formulation |
| 04/22/1999 | WO1999018930A2 Pharmaceutical preparations |
| 04/22/1999 | WO1999018919A2 Topical compositions for regulating the oily/shiny appearance of skin |
| 04/22/1999 | WO1999018798A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/22/1999 | WO1999018794A1 Method for treating alzheimer's disease |
| 04/22/1999 | WO1999018793A1 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 04/22/1999 | WO1999013886B1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 04/22/1999 | WO1999013717B1 A delivery of arginine to cause beneficial effects |
| 04/22/1999 | WO1999011624B1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 04/22/1999 | WO1999006387A3 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents |
| 04/22/1999 | WO1999006361A3 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 04/22/1999 | WO1999006035A3 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 04/22/1999 | WO1999004011A3 Hiv-1 group o antigens and uses thereof |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1999001118A3 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 04/22/1999 | WO1998053068A9 Smad7 and uses thereof |